Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

Chatzidionysiou, Katerina; Lie, Elisabeth; Nasonov, Evgeny; Lukina, Galina; Hetland, Merete Lund; Tarp, Ulrik; Ancuta, Ioan; Pavelka, Karel; Nordström, Dan C; Gabay, Cem; Canhão, Helene; Tomsic, Matija; van Riel, Piet L C M; Gomez-Reino, Juan; Kvien, Tore K; van Vollenhoven, Ronald F

doi:10.1186/s13075-016-0951-z

Scientific article

English

Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

ContributorsChatzidionysiou, Katerina; Lie, Elisabeth; Nasonov, Evgeny; Lukina, Galina; Hetland, Merete Lund; Tarp, Ulrik; Ancuta, Ioan; Pavelka, Karel; Nordström, Dan C; Gabay, Cem; Canhão, Helene; Tomsic, Matija; van Riel, Piet L C M; Gomez-Reino, Juan; Kvien, Tore K; van Vollenhoven, Ronald F

Published inArthritis Research and Therapy, vol. 18, 50

Publication date2016

Abstract

The approved dose of rituximab (RTX) in rheumatoid arthritis is 1000 mg × 2, but some data have suggested similar clinical efficacy with 500 mg × 2. The purpose of this study was to compare the effectiveness of the regular and low doses given as first treatment course.

Keywords

Adult
Aged
Antirheumatic Agents/administration & dosage
Arthritis
Rheumatoid/diagnosis/drug therapy/epidemiology
Cohort Studies
Cooperative Behavior
Databases
Factual
Dose-Response Relationship
Drug
Europe/epidemiology
Female
Humans
Internationality
Male
Middle Aged
Registries
Rituximab/administration & dosage
Statistics as Topic/methods
Treatment Outcome

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Inflammation articulaire (44)

Citation (ISO format)

CHATZIDIONYSIOU, Katerina et al. Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration. In: Arthritis Research and Therapy, 2016, vol. 18, p. 50. doi: 10.1186/s13075-016-0951-z

Article (Published version)

OA OTHER

Identifiers

PID : unige:99458
DOI : 10.1186/s13075-016-0951-z
PMID : 26883119

Journal ISSN1478-6354

502views

250downloads

Creation04/09/2017 11:09:00

First validation04/09/2017 11:09:00

Update24/01/2025 14:30:02

Status update24/01/2025 14:30:02

Last indexation24/01/2025 14:38:21

Archive ouverte UNIGE

Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

The approved dose of rituximab (RTX) in rheumatoid arthritis is 1000 mg × 2, but some data have suggested similar clinical efficacy with 500 mg × 2. The purpose of this study was to compare the effectiveness of the regular and low doses given as first treatment course.

Technical informations